SABRIL (vigabatrin) is a prescription medicine used with various other treatments in grownups and youngsters 2 years of age and older with refractory complex partial seizures (CPS) who have not reacted all right to numerous other treatments and if the feasible benefits outweigh the risk of vision loss.
It is recommended that your healthcare provider test your (or your child's) vision prior to or within 4 weeks after starting SABRIL and at the very least every 3 months throughout therapy until SABRIL is stopped. Tell your doctor if you or your child have any side effect that bothers you or that does not disappear.
Tell your healthcare provider if you are expectant or intend to obtain expecting. If vision screening can not be done, your doctor may proceed prescribing SABRIL, however will not be able to expect any kind of vision loss. If vision tests are refrained on a regular basis, your healthcare provider may stop recommending SABRIL for you (or your child).